期刊文献+

(4S,5S)-4,5-双(胺甲酰基)-2-(2-溴苯基)-1,3-二氧戊环的合成、谱学表征及其晶体结构

Synthesis,Spectrum Characterization and Crystal Structure of (4S,5S)-4,5-dicarboxamide-2-(2-bromophenyl)-1,3-dioxolane
下载PDF
导出
摘要 (4S,5S)-4,5-双(胺甲酰基)-2-(2-溴苯基)-1,3-二氧戊环是合成铂类抗癌药的关键中间体。以邻溴苯甲醛为原料,与D-酒石酸二乙酯进行缩合反应,再经胺解得到标题化合物。通过探讨反应物摩尔比、催化剂用量、反应时间对反应结果的影响,得到最佳反应条件:n(D-酒石酸二乙酯)∶n(邻溴苯甲醛)=1.3∶1,催化剂用量为反应物总质量的4.5%,10 mL环己烷,回流反应6 h;常温导入氨气反应4 h,粗产物Ⅰ经乙醇重结晶,收率67.1%,熔点113~114℃。以无水乙醇为溶剂,经溶剂挥发得到目标产物单晶,并通过熔点、元素分析、MS、1HNMR和X射线单晶衍射仪确定了产物结构。对产物进行了谱学表征和晶体结构分析。该晶体属于单斜晶系,P21空间群,晶胞参数:a=94.150(19)nm,b=144.58(3)nm,c=96.170(19)nm,α=90.00°,β=111.14(3)°,γ=90.00°,V=1.2210(5)nm^3,Dx=1.714 g/cm^3,Z=4,F(000)=632,μ=3.38 mm^-1,S=1.00,R=0.063,wR=0.181。 (4S,5S)-4,5-dicarboxamide-2-(2-bromophenyl)-1,3-dioxolane is the key intermediate which can be synthesized for anticancer drugs.The title compound was synthesized from 2-bromobenzaldehyde and D-ethyl tartrate as starting materials,which can be prepared by the condensation reaction and ammonolyzed by ammonia.The effects of ratio of substances,amount of catalyst and reaction time on yield were discussed.The most favorite technological conditions of title compound(Ⅰ) were determined as follows:n(D-ethyl tartrate)∶n(2-bromobenzaldehyde)=1.3∶1,catalyst dosage=4.5% of mass of the reactants,cyclohexane 10 mL,reaction time 6 h;pumped ammonia 4 h at room temperature,recrystallized from ethanol to obtain final product,the yield was 67.1%,m.p.113~114 ℃.The single crystal was obtained by dissolving product in ethanol and evaporating at room temperature.The structure of the product was characterized by melting point,elementary analysis,MS,^1HNMR and X-ray single crystal diffraction.The crystal belongs to monoclinic system with space group P21 and crystallographic data of the compound are:a=94.150(19) nm,b=144.58(3)nm,c=96.170(19) nm,α=90.00°,β=111.14(3)°,γ=90.00°,V=1.2210(5)nm^3,Dx=1.714 g/cm^3,Z=4,F(000)=632,μ=3.38 mm^-1,S=1.00,R=0.063,wR=0.181.
出处 《精细化工》 EI CAS CSCD 北大核心 2010年第3期309-312,共4页 Fine Chemicals
关键词 缩醛 胺解 晶体结构 精细化工中间体 aldol condensation aminolysis crystal structure fine chemical intermediates
  • 相关文献

参考文献9

  • 1Kim D K, Kim H T, Cho Y B,et al. Antlcaneer activity of cismalonato [ ( 4R, 5R ) -4, 5-bis ( aminomethyl ) -2-isopropyl-1, 3- dioxoane] platinum ( Ⅱ ), a new platinum analogue, as an antieaneer agent [ J ]. Cancer C hemother Pharmacol, 1995,44 (5) : 441 -445.
  • 2Hong W S, Kim H T, Kim K H, et al. In vitro antitumor activity of a new platinum complex, cis-malonato [ (4R, 5R )-4, 5-bis ( aminomethyl ) -2-isopropyl-1, 3-dioxoane ] platinum ( Ⅱ) ( SKI 2053R) ,against human stomach and lung cancer cell lines [ J]. Anticancer Res, 1995,15 ( 1 ) :51 - 54.
  • 3Choi C H,Cha Y J,An C S,et al. Molecular mechanisms of heptaplatin effective against cisplatin-resistant cancer cell lines: less involvement of metallothionein [ J ]. Cancer Cell International, 2004,4(6) :1 - 12.
  • 4Lee W S, Lee G W, K H W, et al. A phase Ⅱ trial of heptaplatin/ 5-FU and leucovorin for advanced stomach cancer [ J ]. Cancer Research and Treatment, 2005,37 (4) : 208 - 211.
  • 5Min Y J,Bang S J,Shin J W,et al. Combination chemotherapy with 5-fluorouracil and heptaplatin as first-line treatment in patients with advanced gastric cancer[ J ]. J Korean Med Sci ,2004,19 (3) : 369 - 373.
  • 6Kim D K, Kim G, Gam J, et al. Synthesis and antitumor activity of a series of [ 2-substituted-4,5-bis ( aminomethyl ) -1,3-dioxolane ] platinum( Ⅱ ) complexes [ J ]. J Med Chem, 1994,37 ( 10 ) : 1471 - 1485.
  • 7Sbovata S M, Bettio F, Mozzon M. Cisplatinum and transplatinum complexes with benzyliminoethcr ligands : synthesis, characterization, structure-activity relationships,and in vitro and in vivo antitumor efficacy [ J ]. J Med Chem, 2007,50 ( 19 ) :4775 - 4784.
  • 8彭安顺,宋兴良.甲基磺酸催化合成苯甲醛VC缩醛的研究[J].应用化工,2009,38(6):840-841. 被引量:4
  • 9Sheldrick G M. SHELX97 : Program for crystal structure refinement [ M ]. Germany : University of Gottingen, 1997.

二级参考文献8

  • 1无可克.功能性化妆品[M].北京:化学工业出版社,2006:38-40.
  • 2Motoyoshi K,Suzuki T.Cosmetics containing novel ascorbic derivatives:JP,08269074[P].1996-10-15.
  • 3Mouhtady O,Gaspard-Houghmane H,Roques N,et al.Metal triflates-methanesufonic acid as new catalytic systems application to the Fries rearrangement[J].Tetrahedron Lett,2003,44:6379-6382.
  • 4Scrivanti A,Beghetto V,Zanato M,et al.Carbonylation of terminal aldynes catalysed by Pd complexes in combination with tri(2-furyl)phosphine and methanesulfonic acid[J].J Mol Catal A:Chem,2000,160:331-336.
  • 5Luong B X,Petre A L,Hoelderich W F,et al.Use methanesulfonic acid as catalyst for the production linear alkylbenzenes[J].J Catal,2004,226:301-307.
  • 6高荫榆,雷占兰,谢何融,郭磊.L-抗坏血酸棕榈酸酯的抗氧化效果研究[J].食品科学,2007,28(11):60-62. 被引量:28
  • 7郑大贵,余衍文,朱华龙,叶红德.辛醛VC缩醛的合成及其在茶籽油中的抗氧化性能[J].化学研究与应用,2008,20(3):356-359. 被引量:4
  • 8何莉斌,宁正祥,李娜.甲氧羰基丙烯酸-6-L抗坏血酸酯的合成及抗氧化活性研究[J].食品工业科技,2009,30(2):265-267. 被引量:4

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部